Records containing: Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-11-13A Phase 1 Study of Topotecan Liposomes Injection (TLI) in Subjects With Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-10-26Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
-
CLINICAL_TRIALS study record update · 2020-09-30A Phase I Trial to Investigate the Tolerability, Safety, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Japanese Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion Part in Asian Subjects With Gastric Cancer
-
CLINICAL_TRIALS study record update · 2020-09-30An Open-label Phase 1b Study of ARQ 092 in Combination With Other Antineoplastic Agents in Subjects With Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-10An Investigator Sponsored Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Doses Followed by Dose Expansion of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Asian Patients With Advanced or Metastatic Solid Tumor Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-09-10A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1 Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A First-in-Human, Open-label, Phase 1 Dose-Escalation Study of 609A in Subjects With Locally Advanced/Metastatic Solid Tumors in China
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1 Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1b Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2020-09-03Evaluation Kanitinib Treatment of Recurrent or Metastatic Malignant Solid Tumors Safety, Tolerability and Pharmacokinetic Open, Dose Escalation Phase I Clinical Study
-
CLINICAL_TRIALS study record update · 2020-09-03A First-in-Human, Open-Label, Multicenter, Dose-Escalation Phase I Clinical Study of Single-Agent RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase 1 Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-07-30A Phase I Study to Evaluate the Safety,Tolerability and Pharmacokinetics of RC48-ADC for Injection in Subjects With Advanced Malignant Solid Tumors With HER2-positive
-
CLINICAL_TRIALS study record update · 2020-07-16A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-07-14Registry Study for Personalized Cancer Therapy
-
CLINICAL_TRIALS study record update · 2020-07-10A Phase 1, Open-Label, Multiple-Ascending-Dose Study of DS-2248, an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-06-22A Phase 1b, Open-Label, Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-06-04A Tolerance, Safety and Pharmacokinetic Ascending Dose Phase I Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive Malignant in Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-05-29A Phase 1, Open-Label, Dose-Escalation, Dose-Expansion, Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
-
CLINICAL_TRIALS study record update · 2020-05-28A Phase I Study of Indoximod [1-methyl-D-tryptophan (D-1MT)] in Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-05-28Evaluation of an Alternative Schedule for CRLX101 Alone in Combination With Bevacizumab and in Combination With mFOLFOX6 in Subjects With Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2020-05-21An Open-Label, Multicenter, Nonrandomized, Dose-Escalation, and Tumor-Expansion Phase 1/2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat (INCB024360), With or Without Pembrolizumab, in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-04-17Phase I/II Randomized Clinical Trial of Neoadjuvant Paclitaxel Versus Priming With BIBF 1120 BIBF 1120 Followed by Plus Paclitaxel in Breast Cancer With HER-2 Negative Correlative Proteomic Studies. and Dynamic Image